U.S. officials inspected wrong Chinese factory

02/18/2008 | ABC News

The FDA on Monday said that instead of investigating a Chinese manufacturer of an ingredient for Baxter International's blood thinner heparin, it inspected another facility with a similar name. The agency said the incident was an isolated case and that it will visit the Chinese factory this week. Baxter's plant in Cherry Hill, N.J., and another supplier's facility in Waunakee, Wis., are also undergoing inspection.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI